SmartCella and Heqet Therapeutics enter into licensing agreement regarding the Extroducer® delivery platform

SmartCella and Heqet Therapeutics enter into licensing agreement regarding the Extroducer® delivery platform Press release Stockholm and Turin June 23, 2026 SmartCella Holding AB (“SmartCella”)and Heqet Therapeutics Srl (“Heqet”), today announced a licensing agreement under which Heqet has the right to use the Extroducer® platform to deliver certain RNA compounds for cardiac regeneration following myocardial […]